Article 26 Oct 2026 DOJ Directive Signals FDA-Regulated Industries May Be Subject To Enhanced Scrutiny United States Government
Article 21 Sep 2026 FDA Workshop Signals Potential Approval Pathway For Testosterone Therapy In Menopausal Women United States Healthcare
Article 19 Aug 2026 FDA Releases Draft GDUFA, PDUFA Commitment Letters As User Fee Reauthorizations Move Forward United States Healthcare
Article 12 Aug 2026 Key Considerations for Acquirers Entering the Peptides and Wellness Business United States Commercial
Article 05 Aug 2026 FDA Advisory Committee Endorses Compounding Of Certain Peptides United States Healthcare
Article 16 Jul 2026 FDA Releases Draft Commitments Letter For Medical Devices Review, Public Meeting Scheduled United States Healthcare
Article 25 Jun 2026 WuXi AppTec Added To DOW's 1260H List: The BIOSECURE Act Clock Is Running United States Healthcare
Article 25 Apr 2026 Congress Takes Up Slate Of FDA Bills Aimed At Reforming Food Regulations United States Healthcare
Article 23 Apr 2026 Cannabis Rescheduling: DOJ Announces Rescheduling Of Certain Products United States Cannabis
Article 17 Mar 2026 FDA User Fee Act Reauthorization: What Happens Next And Positioning For Possible Reform United States Healthcare
Article 09 Jan 2026 Food And Drug Administration: What To Watch In 2026 And Beyond United States Healthcare
Article 11 Dec 2025 FDA Publishes New Draft Guidance On Reducing Animal Testing In Nonclinical Safety Studies United States Healthcare
Article 23 Oct 2025 FDA Announces Inaugural Products To Receive Commissioner's National Priority Vouchers United States Healthcare
Article 09 Oct 2025 FDA Publishes New Draft Guidance On Regenerative Medicine Therapies United States Healthcare
Article 01 Oct 2025 FDA, HHS Taking Action Against Telehealth's Compounded Drug Advertising United States Healthcare
Article 22 Sep 2025 MAHA Commission Shares Strategy: Potential Impacts On Agriculture, Food And Chemical Industries United States Healthcare
Article 17 Sep 2025 MAHA Commission Report Details Federal Response To Childhood Chronic Disease United States Healthcare